Chimerix Company Insiders
| CMRX Stock | USD 8.47 0.01 0.12% |
Chimerix's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Chimerix suggests that vertually all insiders are panicking. Chimerix employs about 72 people. The company is managed by 12 executives with a total tenure of roughly 22 years, averaging almost 1.0 years of service per executive, having 6.0 employees per reported executive.
| Michael Alrutz CEO interim CEO, Senior Vice President General Counsel |
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
| 2025-02-13 | Michelle Laspaluto | Disposed 2260 @ 4.51 | View | ||
| 2025-01-30 | Michelle Laspaluto | Disposed 1015 @ 4.11 | View | ||
| 2024-08-08 | Michael T Andriole | Disposed 1285 @ 0.83 | View |
Monitoring Chimerix's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Chimerix |
Chimerix's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Chimerix's future performance. Based on our forecasts, it is anticipated that Chimerix will maintain a workforce of slightly above 70 employees by April 2025.Chimerix Management Team Effectiveness
The company has return on total asset (ROA) of (0.3022) % which means that it has lost $0.3022 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4859) %, meaning that it created substantial loss on money invested by shareholders. Chimerix's management efficiency ratios could be used to measure how well Chimerix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.47 in 2025. Return On Capital Employed is likely to drop to -0.58 in 2025. At this time, Chimerix's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 363.5 K in 2025, whereas Total Assets are likely to drop slightly above 197 M in 2025.Common Stock Shares Outstanding is likely to rise to about 107 M in 2025. Net Income Applicable To Common Shares is likely to rise to about 207.9 M in 2025
Chimerix Workforce Comparison
Chimerix is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,032. Chimerix holds roughly 72.0 in number of employees claiming about 7% of equities under Health Care industry.
Chimerix Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chimerix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chimerix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Chimerix insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2025-03-01 | 1.5 | 12 | 8 | 2,409,389 | 20,760 |
| 2024-03-01 | 3.6667 | 11 | 3 | 1,286,500 | 6,344 |
| 2023-12-01 | 0.3846 | 5 | 13 | 937,000 | 140,236 |
| 2023-09-01 | 4.0 | 4 | 1 | 213,000 | 3,610 |
| 2023-03-01 | 5.5 | 11 | 2 | 1,262,400 | 67,505 |
| 2022-09-01 | 1.3333 | 4 | 3 | 270,000 | 154,400 |
| 2022-03-01 | 0.5 | 6 | 12 | 1,699,800 | 730,535 |
| 2021-06-01 | 3.6667 | 11 | 3 | 320,250 | 6,534 |
| 2021-03-01 | 2.0 | 6 | 3 | 1,186,500 | 263,211 |
| 2020-12-01 | 1.0 | 3 | 3 | 15,584 | 18,354 |
| 2020-09-01 | 0.5 | 5 | 10 | 15,084 | 28,168 |
| 2020-06-01 | 8.0 | 8 | 1 | 645,000 | 0.00 |
| 2020-03-01 | 1.4286 | 10 | 7 | 1,349,270 | 271,392 |
| 2019-09-01 | 0.5 | 1 | 2 | 56,000 | 7,625 |
| 2019-06-01 | 2.0 | 16 | 8 | 2,057,000 | 25,740 |
| 2019-03-01 | 0.7 | 7 | 10 | 1,201,000 | 425,528 |
| 2018-06-01 | 0.9231 | 12 | 13 | 197,700 | 190,293 |
| 2018-03-01 | 1.3333 | 8 | 6 | 961,321 | 156,891 |
| 2017-06-01 | 3.3333 | 10 | 3 | 197,815 | 46,353 |
| 2017-03-01 | 12.0 | 12 | 1 | 491,258 | 45,750 |
| 2016-12-01 | 0.2 | 1 | 5 | 2,400 | 102,400 |
| 2016-09-01 | 2.0 | 4 | 2 | 35,144 | 15,000 |
| 2016-06-01 | 10.5 | 21 | 2 | 487,343 | 3,521 |
| 2016-03-01 | 2.3333 | 14 | 6 | 1,434,883 | 204,433 |
| 2015-12-01 | 0.7 | 7 | 10 | 143,408 | 11,534 |
| 2015-09-01 | 0.7222 | 13 | 18 | 50,953 | 98,203 |
| 2015-06-01 | 1.5385 | 20 | 13 | 106,853 | 19,920 |
| 2015-03-01 | 1.1176 | 19 | 17 | 505,724 | 45,524 |
| 2014-12-01 | 1.2857 | 9 | 7 | 60,905 | 28,962 |
| 2014-09-01 | 0.3488 | 15 | 43 | 766,182 | 4,094,879 |
| 2014-06-01 | 2.8889 | 26 | 9 | 412,331 | 73,716 |
| 2014-03-01 | 0.6316 | 12 | 19 | 552,900 | 4,091,818 |
| 2013-12-01 | 0.7742 | 24 | 31 | 268,946 | 4,414,687 |
| 2013-06-01 | 2.5294 | 43 | 17 | 31,369,565 | 1,472,655 |
Chimerix Notable Stakeholders
A Chimerix stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Chimerix often face trade-offs trying to please all of them. Chimerix's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Chimerix's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael MBA | President CEO | Profile | |
| Michael Alrutz | interim CEO, Senior Vice President General Counsel | Profile | |
| Dr JD | General VP | Profile | |
| MD MBA | Chief Officer | Profile | |
| David CPA | Exec Officer | Profile | |
| Joshua Allen | Chief Imipridones | Profile | |
| Dr MBA | Chief Officer | Profile | |
| Pablo MD | Head Affairs | Profile | |
| Roy Ware | Chief Manufacturing and Technology Officer | Profile | |
| Thomas Riga | Chief Officer | Profile | |
| Randall Lanier | Chief Science Officer | Profile | |
| Michelle LaSpaluto | Chief Officer | Profile |
About Chimerix Management Performance
The success or failure of an entity such as Chimerix often depends on how effective the management is. Chimerix management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Chimerix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Chimerix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.44) | (0.47) | |
| Return On Capital Employed | (0.55) | (0.58) | |
| Return On Assets | (0.44) | (0.47) | |
| Return On Equity | (0.38) | (0.40) |
Please note, the imprecision that can be found in Chimerix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Chimerix. Check Chimerix's Beneish M Score to see the likelihood of Chimerix's management manipulating its earnings.
Chimerix Workforce Analysis
Traditionally, organizations such as Chimerix use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Chimerix within its industry.Chimerix Manpower Efficiency
Return on Chimerix Manpower
| Revenue Per Employee | 4.5K | |
| Revenue Per Executive | 27K | |
| Net Loss Per Employee | 1.1M | |
| Net Loss Per Executive | 6.8M | |
| Working Capital Per Employee | 2.4M | |
| Working Capital Per Executive | 14.2M |
Additional Tools for Chimerix Stock Analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.